Publications by authors named "Ina Eilertsen"

Claim this Profile
M
Molecular prognostic factors for liver transplantation of unresectable metastatic colorectal cancer.
Seyed H Moosavi, Kushtrim Kryeziu, Ina A Eilertsen, Luís Nunes, Merete Hektoen

Br J Surg· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration.
Umair Majid, Christian Holst Bergsland, Anita Sveen, Jarle Bruun, Ina Andrassy Eilertsen

Cell Oncol (Dordr)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.
Jonas Langerud, Ina A Eilertsen, Seyed H Moosavi, Solveig M K Klokkerud, Henrik M Reims

Nat Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Maren Høland, Kaja C G Berg, Ina A Eilertsen, Bodil Bjerkehagen, Matthias Kolberg

EBioMedicine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Seyed H Moosavi, Peter W Eide, Ina A Eilertsen, Tuva H Brunsell, Kaja C G Berg

Genome Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expressed mutational landscape of microsatellite stable colorectal cancers.
Anita Sveen, Bjarne Johannessen, Ina A Eilertsen, Bård I Røsok, Marie Gulla

Genome Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer.
Peter W Eide, Seyed H Moosavi, Ina A Eilertsen, Tuva H Brunsell, Jonas Langerud

NPJ Genom Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity.
Jørgen Smeby, Kushtrim Kryeziu, Kaja C G Berg, Ina A Eilertsen, Peter W Eide

EBioMedicine· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity.
Jarle Bruun, Kushtrim Kryeziu, Peter W Eide, Seyed H Moosavi, Ina A Eilertsen

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer.
Ina A Eilertsen, Seyed H Moosavi, Jonas M Strømme, Arild Nesbakken, Bjarne Johannessen

Cancer Lett· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell-intrinsic properties.
Peter W Eide, Ina A Eilertsen, Anita Sveen, Ragnhild A Lothe

Int J Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory analyses of consensus molecular subtype-dependent associations of mutations with immunomodulation and prognosis in colorectal cancer.
Jørgen Smeby, Anita Sveen, Christian H Bergsland, Ina A Eilertsen, Stine A Danielsen

ESMO Open· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer.
Jørgen Smeby, Anita Sveen, Ina A Eilertsen, Stine A Danielsen, Andreas M Hoff

Oncogenesis· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer.
Ina A Eilertsen, Anita Sveen, Jonas M Strømme, Rolf I Skotheim, Arild Nesbakken

Int J Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53.
Maren Høland, Matthias Kolberg, Stine Aske Danielsen, Bodil Bjerkehagen, Ina A Eilertsen

Mod Pathol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
Jarle Bruun, Anita Sveen, Rita Barros, Peter W Eide, Ina Eilertsen

Mol Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies.
Anita Sveen, Jarle Bruun, Peter W Eide, Ina A Eilertsen, Lorena Ramirez

Clin Cancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors.
Matthias Kolberg, Jarle Bruun, Astrid Murumägi, John P Mpindi, Christian H Bergsland, Ina A Eilertsen

Mol Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Kaja C G Berg, Peter W Eide, Ina A Eilertsen, Bjarne Johannessen, Jarle Bruun

Mol Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1.
Anita Sveen, Bjarne Johannessen, Torstein Tengs, Stine A Danielsen, Ina A Eilertsen

Genome Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1.
João Ramalho-Carvalho, João Barbosa Martins, Lina Cekaite, Anita Sveen, Jorge Torres-Ferreira, Ina Andrassy Eilertsen

Cancer Lett· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.
Hege Marie Vedeld, Kim Andresen, Ina Andrassy Eilertsen, Arild Nesbakken, Raquel Seruca

Int J Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
Peter W Eide, Lina Cekaite, Stine A Danielsen, Ina A Eilertsen, Ane Kjenseth

Cell Signal· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis